Study to Determine the Safety of Two Applications of PEP005 Topical Gel to Cutaneous Squamous Cell Carcinoma In Situ
Status:
Completed
Trial end date:
2006-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether the topical application of PEP005 is safe
and effective for the treatment of cutaneous squamous cell carcinoma in situ (SCCIS, Bowen's
disease).